J.P. Morgan Reiterates Roche Holding (RHHBY)’s “Buy” Rating; Last Week DekelOil Public Limited (LON:DKL) Coverage

The stock decreased 0.10% or $0.03 during the last trading session, reaching $31.52. About 144,918 shares traded. Roche Holding AG (RHHBY) has 0.00% since December 29, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 2 analysts covering DekelOil Public Ltd (LON:DKL), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. DekelOil Public Ltd had 57 analyst reports since August 13, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Buy” rating and GBX 29 target in Monday, November 14 report. The company was maintained on Thursday, November 19 by Beaufort Securities. The company was maintained on Wednesday, June 7 by Beaufort Securities. The stock has “Buy” rating by Beaufort Securities on Monday, April 10. On Tuesday, January 17 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The firm earned “Buy” rating on Tuesday, November 15 by Beaufort Securities. The firm has “Buy” rating by Beaufort Securities given on Thursday, June 29. The company was maintained on Wednesday, March 16 by Cantor Fitzgerald. As per Wednesday, November 18, the company rating was maintained by Cantor Fitzgerald. The stock of DekelOil Public Limited (LON:DKL) earned “Buy” rating by Cantor Fitzgerald on Friday, June 17. See DekelOil Public Limited (LON:DKL) latest ratings:

25/10/2017 Broker: Beaufort Securities Rating: Buy Old Target: GBX 23.00 New Target: GBX 23.00 Maintain
19/10/2017 Broker: Beaufort Securities Rating: Buy Old Target: GBX 23.00 New Target: GBX 23.00 Maintain
28/09/2017 Broker: Beaufort Securities Rating: Buy Old Target: GBX 23.00 New Target: GBX 23.00 Maintain
27/09/2017 Broker: Cantor Fitzgerald Rating: Buy Old Target: GBX 25.00 New Target: GBX 24.00 Maintain
04/08/2017 Broker: Beaufort Securities Rating: Buy Old Target: GBX 23.00 New Target: GBX 23.00 Maintain
26/07/2017 Broker: Beaufort Securities Rating: Buy Old Target: GBX 23.00 New Target: GBX 23.00 Maintain
19/07/2017 Broker: Beaufort Securities Rating: Buy Old Target: GBX 23.00 New Target: GBX 23.00 Maintain

Roche Holding AG operates in the pharmaceuticals and diagnostics businesses worldwide. The company has market cap of $219.94 billion. The firm offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, drug metabolism disorder, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, human papillomavirus, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and west nile virus diseases. It has a 22.2 P/E ratio. It also provides diagnostic solutions for blood gas analysis; blood screening; cancer screening; cardiac markers; cardiovascular testing; cholesterol monitoring; coagulation monitoring, routing, and specialty testing; data management; diabetes monitoring and therapy; electrolytes analysis; emergency medicine; hemostasis; heterogeneous immunochemistry; homogenous immune assays; immunology; infectious diseases; intensive care testing; microarray; anti-platelet therapy monitoring; neonatal intensive care; nucleic acid purification; PCR clinical diagnostics and real-time PCR diagnostic systems; pharmacogenomics; physical fitness and platelet function testing; serum work area; urinalysis; and workflow solutions.

DekelOil Public Limited, through its subsidiaries, develops and cultivates palm oil plantations in the Republic of Cote d'Ivoire. The company has market cap of 26.85 million GBP. The firm produces and markets crude palm oil. It has a 11.25 P/E ratio. It owns approximately 1,900 hectares of plantations.

It closed at GBX 9 lastly. It is down 0.00% since December 29, 2016 and is . It has underperformed by 16.70% the S&P500.